Diagnosis involves identifying ganglion cells through hematoxylin and eosin staining, and markers like S100 proteins and neuron-specific enolase.5 Differential diagnosis includes schwannomas and neurofibromas; however, these do not exhibit ganglion cells. Here, ENO2 is linked to neurofibroma.